Stuart J. Pocock

Showing 1-2 of 2 articles

Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy

Jensen C, Naber C, Urban P, Ong PJ, Valdés Chávarri M, Abizaid A, Pocock S, Fabbiocchi F, Dubois C, Copt S, Stoll H-P, Morice M

March 20, 2018 | 10.4244/EIJ-D-17-00720

Coronary interventions

Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial

Kappetein AP, Serruys P, Sabik J, Leon M, Taggart D, Morice M, Gersh B, Pocock S, Cohen D, Wallentin L, Ben-Yehuda O, Van Es G-A, Simonton C, Stone G

September 18, 2016 | 10.4244/EIJV12I7A141

1

Latest news

LM revascularisation, annulus rupture, risk stratification, renal denervation

EAPCI survey results: The impact of COVID-19

Marco Roffi, Dariusz Dudek, et al.

A perspective from EAPCI Women and Women as One

Gill Louise Buchanan

Last Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

EuroIntervention new Editorial Board

This week’s JAA’s: Paradigm Study: 12months outcome, GLASSY ACS vs SIHD...

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke